Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 19;20(1):77.
doi: 10.1186/s12974-023-02734-9.

Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds

Affiliations
Review

Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds

Brittney R Lins et al. J Neuroinflammation. .

Abstract

Traumatic brain injury is common, and often results in debilitating consequences. Even mild traumatic brain injury leaves approximately 20% of patients with symptoms that persist for months. Despite great clinical need there are currently no approved pharmaceutical interventions that improve outcomes after traumatic brain injury. Increased understanding of the endocannabinoid system in health and disease has accompanied growing evidence for therapeutic benefits of Cannabis sativa. This has driven research of Cannabis' active chemical constituents (phytocannabinoids), alongside endogenous and synthetic counterparts, collectively known as cannabinoids. Also of therapeutic interest are other Cannabis constituents, such as terpenes. Cannabinoids interact with neurons, microglia, and astrocytes, and exert anti-inflammatory and neuroprotective effects which are highly desirable for the management of traumatic brain injury. In this review, we comprehensively appraised the relevant scientific literature, where major and minor phytocannabinoids, terpenes, synthetic cannabinoids, and endogenous cannabinoids were assessed in TBI, or other neurological conditions with pathology and symptomology relevant to TBI, as well as recent studies in preclinical TBI models and clinical TBI populations.

Keywords: CNS injury; Concussion; Endocannabinoid system; Inflammation; Neuroprotection; Neurotrauma; Terpenes; Traumatic brain injury.

PubMed Disclaimer

Conflict of interest statement

This was an industry-sponsored project. Funding from MediCann Health Aust Pty Ltd included salary support for BRL during the tenure of this project. MS is the CEO of MediCann Health Aust Pty Ltd. LDP is a Director of MediCann Health Aust Pty Ltd. MF is the CEO of Connectivity Traumatic Brain Injury Australia. All other authors declare that they have no competing interests.

References

    1. Corrigan JD, Selassie AW, Orman JA. The epidemiology of traumatic brain injury. J Head Trauma Rehabil. 2010;25(2):72–80. doi: 10.1097/HTR.0b013e3181ccc8b4. - DOI - PubMed
    1. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21(5):375–378. doi: 10.1097/00001199-200609000-00001. - DOI - PubMed
    1. Baxter K, Hellewell SC. Traumatic brain injury within domestic relationships: complications, consequences and contributing factors. J Aggress Maltreatment Trauma. 2019;28(6):660–676. doi: 10.1080/10926771.2019.1602089. - DOI
    1. Meaney DF, Smith DH. Biomechanics of concussion. Clin Sports Med. 2011;30(1):19. doi: 10.1016/j.csm.2010.08.009. - DOI - PMC - PubMed
    1. Menon DK, Schwab K, Wright DW, Maas AI. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010;91(11):1637–1640. doi: 10.1016/j.apmr.2010.05.017. - DOI - PubMed